N-methyl-N-(4-(trifluoromethyl)benzo[d]thiazol-2-yl)glycine, 95.0%, 250mg

3-hydroxy-N-methylpropanamide, 95.0%, 10g

6-bromo-2-methyl-2H-pyrazolo[4,3-b]pyridine, 97.0%, 5g

2-Amino-1-(3-methylphenyl)ethan-1-one hydrochloride, 98%, 250mg

(1-(thiazol-4-ylmethyl)piperidin-4-yl)methanol, 95.0%, 250mg

(2S,5S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-5-methylpyrrolidine-2-carboxylic acid, 97%, 250mg

(R)-4,4-difluoropyrrolidine-2-carboxamide hydrochloride, 98%, 5g

(2E)-3-(4-fluorophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Objetivo E-plan EPL 10x/0,25

(5r)-5-Phenylmorpholin-2-one hydrochloride, 95%, 1g

6-(2-aminoethyl)-2-methyl-4-pyrimidinol dihydrochloride hydrate, 95.0%, 5g

Methyl 2-fluoro-5-(methylsulfanyl)benzoate, 95%, 500mg

2-Bromo-6-nitrobenzaldehyde, 95.0%, 25g